HRS Partnership
Hyper Recruitment Solutions (HRS) are working in partnership with BPL Therapeutics on a number of specialist scientific roles. We our using our expertise and our knowledge of the marketplace to reach out to key individuals whom BPL Therapeutics are looking to employ. This is all being done in a collaborative, professional and timely manner. If you’re looking for career opportunities and you would like to discuss any of the roles that we are working on with BPL, please apply via our website or contact us directly.
BPL Therapeutics (based in Elstree, UK) houses BPL Group’s headquarters as well as its manufacturing, quality, R&D, finance, and commercial operations.
BPL Therapeutics employs over 1,000 people.
Using the plasma collected by BPL Plasma in the United States, BPL Therapeutics fractionates around 1.5 million litres annually from 3 production lines to manufacture a wide range of therapeutic products, which are then supplied to patients in more than 50 countries around the world.
The fractionation process separates the components of plasma and extracts proteins which are isolated, purified and concentrated by BPL using state-of-the-art plasma fractionation and purification technologies. These proteins are formulated into products which treat serious and life-threatening conditions.
BPL is currently building a new 1,000m2 Filling and Sterilisation Facility at Elstree to expand filling capacity and manufacture new products that are in development.
BPL’s operations are regulated by the MHRA and the DHSC in the UK.
Browse BPL jobs below or contact HRS to find out more about the vacancies we’re helping BPL Therapeutics to fill.
BPL Therapeutics employs over 1,000 people.
Using the plasma collected by BPL Plasma in the United States, BPL Therapeutics fractionates around 1.5 million litres annually from 3 production lines to manufacture a wide range of therapeutic products, which are then supplied to patients in more than 50 countries around the world.
The fractionation process separates the components of plasma and extracts proteins which are isolated, purified and concentrated by BPL using state-of-the-art plasma fractionation and purification technologies. These proteins are formulated into products which treat serious and life-threatening conditions.
BPL is currently building a new 1,000m2 Filling and Sterilisation Facility at Elstree to expand filling capacity and manufacture new products that are in development.
BPL’s operations are regulated by the MHRA and the DHSC in the UK.
Browse BPL jobs below or contact HRS to find out more about the vacancies we’re helping BPL Therapeutics to fill.
